These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3017596)

  • 1. Prospective randomized double-blind trial of nabilone versus domperidone in the treatment of cytotoxic-induced emesis.
    Pomeroy M; Fennelly JJ; Towers M
    Cancer Chemother Pharmacol; 1986; 17(3):285-8. PubMed ID: 3017596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nabilone: an alternative antiemetic for cancer chemotherapy.
    Dalzell AM; Bartlett H; Lilleyman JS
    Arch Dis Child; 1986 May; 61(5):502-5. PubMed ID: 3013104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buprenorphine versus domperidone in chemotherapy-induced emesis: a pilot study.
    Dullemond-Westland AC; Neijt JP; Nortier JW; Sitsen JM
    Radiother Oncol; 1986 Jun; 6(2):127-33. PubMed ID: 3526421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nabilone: an effective antiemetic in patients receiving cancer chemotherapy.
    Einhorn LH; Nagy C; Furnas B; Williams SD
    J Clin Pharmacol; 1981; 21(S1):64S-69S. PubMed ID: 6271844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, controlled trial of nabilone vs. prochlorperazine for refractory emesis induced by cancer chemotherapy.
    Johansson R; Kilkku P; Groenroos M
    Cancer Treat Rev; 1982 Dec; 9 Suppl B():25-33. PubMed ID: 6299551
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy.
    Ahmedzai S; Carlyle DL; Calder IT; Moran F
    Br J Cancer; 1983 Nov; 48(5):657-63. PubMed ID: 6315040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nabilone vs. placebo in the treatment of chemotherapy-induced nausea and vomiting in cancer patients.
    Levitt M
    Cancer Treat Rev; 1982 Dec; 9 Suppl B():49-53. PubMed ID: 6299556
    [No Abstract]   [Full Text] [Related]  

  • 8. High-dose alizapride versus high-dose domperidone: a double-blind comparative study in the management of cis-platinum-induced emesis.
    Huys J; Troch M; Bourguignon RP; Smets P
    Curr Med Res Opin; 1985; 9(6):400-6. PubMed ID: 3886305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind, crossover trial.
    Chan HS; Correia JA; MacLeod SM
    Pediatrics; 1987 Jun; 79(6):946-52. PubMed ID: 3035479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nabilone and prochlorperazine: a useful combination for emesis induced by cytotoxic drugs.
    Cunningham D; Forrest GJ; Soukop M; Gilchrist NL; Calder IT; McArdle CS
    Br Med J (Clin Res Ed); 1985 Sep; 291(6499):864-5. PubMed ID: 2996690
    [No Abstract]   [Full Text] [Related]  

  • 11. Study design for the evaluation of the efficacy and safety of nabilone.
    Stark P
    Cancer Treat Rev; 1982 Dec; 9 Suppl B():35-7. PubMed ID: 6299553
    [No Abstract]   [Full Text] [Related]  

  • 12. Concise review of the management of iatrogenic emesis using cannabinoids: emphasis on nabilone for chemotherapy-induced nausea and vomiting.
    Pergolizzi JV; Taylor R; LeQuang JA; Zampogna G; Raffa RB
    Cancer Chemother Pharmacol; 2017 Mar; 79(3):467-477. PubMed ID: 28235999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in anti-emetic therapy.
    Bakowski MT
    Cancer Treat Rev; 1984 Sep; 11(3):237-56. PubMed ID: 6098368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting.
    Jones SE; Durant JR; Greco FA; Robertone A
    Cancer Treat Rev; 1982 Dec; 9 Suppl B():45-8. PubMed ID: 6299555
    [No Abstract]   [Full Text] [Related]  

  • 15. A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy.
    Niiranen A; Mattson K
    Am J Clin Oncol; 1985 Aug; 8(4):336-40. PubMed ID: 3002167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain.
    Davis MP
    Expert Opin Investig Drugs; 2008 Jan; 17(1):85-95. PubMed ID: 18095921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nabilone: an effective antiemetic agent in patients receiving cancer chemotherapy.
    Einhorn L
    Cancer Treat Rev; 1982 Dec; 9 Suppl B():55-61. PubMed ID: 6299557
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of nabilone in the treatment of chemotherapy-induced vomiting in an outpatient setting.
    Cone LA; Greene DS; Helm NA
    Cancer Treat Rev; 1982 Dec; 9 Suppl B():63-70. PubMed ID: 6299558
    [No Abstract]   [Full Text] [Related]  

  • 19. Double-blind, randomized, crossover trial of nabilone vs. placebo in cancer chemotherapy.
    Wada JK; Bogdon DL; Gunnell JC; Hum GJ; Gota CH; Rieth TE
    Cancer Treat Rev; 1982 Dec; 9 Suppl B():39-44. PubMed ID: 6299554
    [No Abstract]   [Full Text] [Related]  

  • 20. The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.
    de Wit R; Herrstedt J; Rapoport B; Carides AD; Guoguang-Ma J; Elmer M; Schmidt C; Evans JK; Horgan KJ
    Eur J Cancer; 2004 Feb; 40(3):403-10. PubMed ID: 14746859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.